In this second webinar on the topic of canine atopic dermatitis, Dr. Pieper continues his discussion with a focus on moderate to severe cases of disease. His discussion includes:
- Characteristics of moderate to severe disease
- Current therapeutic options including JAK inhibitors (Apoquel and Zenrelia) and when they should be implemented into treatment plans
- The role of monoclonal antibodies and how Cytopoint can be used as part of patient management
- The ideal cases for allergen specific immunotherapy and testing options
Running time: 1 hr 16 mins (including 16 mins of Q&A)
Approved for 1 hour of CE credit by AAVSB RACE and NY State
You might also like
Improving The Quality Of Life For Cats With Chronic Kidney Disease
09/23/2025
Chronic kidney disease (CKD) is one of the most common and challenging conditions affecting older ca...
Read
More
Stem Cell Therapy For Canine Atopic Dermatitis
08/20/2025
Canine atopic dermatitis is a complex disease. Management of patients is often multimodal and includ...
Read
More
Canine Atopic Dermatitis - Pathogenesis, Diagnosis, And Treatment Of Mild Disease
08/12/2025
Canine atopic dermatitis (CAD) is one of the most frustrating and complex skin conditions encountere...
Read
More
The Skinny On Pyoderma - The Most Common Bacterial Infection Of The Skin
08/05/2025
Pyoderma (bacterial skin infection) is one of the most common dermatologic conditions seen in compan...
Read
More
Tackling Itchy And Smelly Ears
07/29/2025
Otitis externa is a common and often recurrent condition affecting the ears of dogs and cats. The co...
Read
More
Supporting The Cancer Patient: Managing Cancer Pain, Nutritional Needs Of Patients, And Supporting The Caregiver Through It All
12/04/2024
Aside from the plan prescribed to treat a pet’s cancer, we have to ensure that we are addressi...
Read
More
